Previous Article | Next Article 
Journal of Clinical Microbiology, June 2000, p. 2232-2239, Vol. 38, No. 6
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Evaluation of Immunoglobulin M (IgM) and IgG Enzyme
Immunoassays in Serologic Diagnosis of West Nile Virus
Infection
G.
Tardei,1
S.
Ruta,2
V.
Chitu,1
C.
Rossi,3
T. F.
Tsai,4,* and
C.
Cernescu2
Institute of Virology1
and Carol Davila University of Medicine and
Pharmacy,2 Bucharest, Romania; U.S. Army
Medical Institute of Infectious Diseases, Fort Detrick, Frederick,
Maryland 21702-50113; and Division of
Vector Borne Infectious Diseases, Centers for Disease Control and
Prevention, Fort Collins, Colorado 805224
Received 1 February 2000/Accepted 22 March 2000
A unique urban encephalitis epidemic in Romania signaled the
emergence of neurological infection due to West Nile (WN) virus as a
novel public health threat in Eastern Europe and provided an
opportunity to evaluate patterns of immunoglobulin G (IgG) and IgM
reactivity in IgM capture and IgG enzyme-linked immunosorbent assays
(ELISAs). WN virus infection was diagnosed serologically in 236 of 290 patients from whom acute serum or cerebrospinal fluid (CSF) samples
were available. In 37% of serum samples and in 25% of CSF samples
collected in the first week of illness, anti-WN virus IgM antibody was
detected in the absence of virus-specific IgG. The switch to an IgG
antibody response occurred after 4 to 5 days of illness and earlier in
CSF than in serum. A specific humoral immune response was detected in
the CSF before the serum in some patients for whom paired CSF and serum
samples from the same day were available. IgM antibody in convalescent
serum samples persisted beyond 2 months after the onset of illness in
more than 50% of patients. ELISA optical density values and antibody
concentrations were well correlated for both IgM and IgG immunoassays.
Anti-WN virus IgM antibody in acute-phase samples did not cross-react significantly with flaviviruses in other antigenic groups.
*
Corresponding author. Present address: Wyeth Lederle
Vaccines, 401 N. Middletown Rd., Pearl River, NY 10965. Phone: (914) 732-4053. E-mail: tsait{at}war.wveth.com.
Journal of Clinical Microbiology, June 2000, p. 2232-2239, Vol. 38, No. 6
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Tyler, K. L.
(2009). Emerging Viral Infections of the Central Nervous System: Part 1. Arch Neurol
66: 939-948
[Abstract]
[Full Text]
-
Shaikh, N. A., Ge, J., Zhao, Y.-X., Walker, P., Drebot, M.
(2007). Development of a novel, rapid, and sensitive immunochromatographic strip assay specific for West Nile Virus (WNV) IgM and testing of its diagnostic accuracy in patients suspected of WNV infection.. Clin. Chem.
53: 2031-2034
[Full Text]
-
Roberson, J. A., Crill, W. D., Chang, G.-J. J.
(2007). Differentiation of West Nile and St. Louis Encephalitis Virus Infections by Use of Noninfectious Virus-Like Particles with Reduced Cross-Reactivity. J. Clin. Microbiol.
45: 3167-3174
[Abstract]
[Full Text]
-
Tyler, K. L., Aksamit, A. J. Jr, Keegan, B. M., Parisi, J. E.
(2007). An 85-year-old man with chronic lymphocytic leukemia and altered mental status. Neurology
68: 460-467
[Full Text]
-
Cordoba, L., Escribano-Romero, E., Garmendia, A., Saiz, J.-C.
(2007). Pregnancy increases the risk of mortality in West Nile virus-infected mice. J. Gen. Virol.
88: 476-480
[Abstract]
[Full Text]
-
Macdonald, J., Tonry, J., Hall, R. A., Williams, B., Palacios, G., Ashok, M. S., Jabado, O., Clark, D., Tesh, R. B., Briese, T., Lipkin, W. I.
(2005). NS1 Protein Secretion during the Acute Phase of West Nile Virus Infection. J. Virol.
79: 13924-13933
[Abstract]
[Full Text]
-
Prince, H. E., Tobler, L. H., Lape-Nixon, M., Foster, G. A., Stramer, S. L., Busch, M. P.
(2005). Development and Persistence of West Nile Virus-Specific Immunoglobulin M (IgM), IgA, and IgG in Viremic Blood Donors. J. Clin. Microbiol.
43: 4316-4320
[Abstract]
[Full Text]
-
Tilley, P. A. G., Walle, R., Chow, A., Jayaraman, G. C., Fonseca, K., Drebot, M. A., Preiksaitis, J., Fox, J.
(2005). Clinical Utility of Commercial Enzyme Immunoassays during the Inaugural Season of West Nile Virus Activity, Alberta, Canada. J. Clin. Microbiol.
43: 4691-4695
[Abstract]
[Full Text]
-
Johnson, A. J., Noga, A. J., Kosoy, O., Lanciotti, R. S., Johnson, A. A., Biggerstaff, B. J.
(2005). Duplex Microsphere-Based Immunoassay for Detection of Anti-West Nile Virus and Anti-St. Louis Encephalitis Virus Immunoglobulin M Antibodies. CVI
12: 566-574
[Abstract]
[Full Text]
-
Hogrefe, W. R., Moore, R., Lape-Nixon, M., Wagner, M., Prince, H. E.
(2004). Performance of Immunoglobulin G (IgG) and IgM Enzyme-Linked Immunosorbent Assays Using a West Nile Virus Recombinant Antigen (preM/E) for Detection of West Nile Virus- and Other Flavivirus-Specific Antibodies. J. Clin. Microbiol.
42: 4641-4648
[Abstract]
[Full Text]
-
Shu, P.-Y., Chen, L.-K., Chang, S.-F., Su, C.-L., Chien, L.-J., Chin, C., Lin, T.-H., Huang, J.-H.
(2004). Dengue Virus Serotyping Based on Envelope and Membrane and Nonstructural Protein NS1 Serotype-Specific Capture Immunoglobulin M Enzyme-Linked Immunosorbent Assays. J. Clin. Microbiol.
42: 2489-2494
[Abstract]
[Full Text]
-
Gea-Banacloche, J., Johnson, R. T., Bagic, A., Butman, J. A., Murray, P. R., Agrawal, A. G.
(2004). West Nile Virus: Pathogenesis and Therapeutic Options. ANN INTERN MED
140: 545-553
[Abstract]
[Full Text]
-
Malan, A. K., Martins, T. B., Hill, H. R., Litwin, C. M.
(2004). Evaluations of Commercial West Nile Virus Immunoglobulin G (IgG) and IgM Enzyme Immunoassays Show the Value of Continuous Validation. J. Clin. Microbiol.
42: 727-733
[Abstract]
[Full Text]
-
Prince, H. E., Lape'-Nixon, M., Moore, R. J., Hogrefe, W. R.
(2004). Utility of the Focus Technologies West Nile Virus Immunoglobulin M Capture Enzyme-Linked Immunosorbent Assay for Testing Cerebrospinal Fluid. J. Clin. Microbiol.
42: 12-15
[Abstract]
[Full Text]
-
Wong, S. J., Demarest, V. L., Boyle, R. H., Wang, T., Ledizet, M., Kar, K., Kramer, L. D., Fikrig, E., Koski, R. A.
(2004). Detection of Human Anti-Flavivirus Antibodies with a West Nile Virus Recombinant Antigen Microsphere Immunoassay. J. Clin. Microbiol.
42: 65-72
[Abstract]
[Full Text]
-
Engle, M. J., Diamond, M. S.
(2003). Antibody Prophylaxis and Therapy against West Nile Virus Infection in Wild-Type and Immunodeficient Mice. J. Virol.
77: 12941-12949
[Abstract]
[Full Text]
-
Prince, H. E., Hogrefe, W. R.
(2003). Detection of West Nile Virus (WNV)-Specific Immunoglobulin M in a Reference Laboratory Setting during the 2002 WNV Season in the United States. CVI
10: 764-768
[Abstract]
[Full Text]
-
Iwamoto, M., Jernigan, D. B., Guasch, A., Trepka, M. J., Blackmore, C. G., Hellinger, W. C., Pham, S. M., Zaki, S., Lanciotti, R. S., Lance-Parker, S. E., DiazGranados, C. A., Winquist, A. G., Perlino, C. A., Wiersma, S., Hillyer, K. L., Goodman, J. L., Marfin, A. A., Chamberland, M. E., Petersen, L. R., the West Nile Virus in Transplant Recipients Inves,
(2003). Transmission of West Nile Virus from an Organ Donor to Four Transplant Recipients. NEJM
348: 2196-2203
[Abstract]
[Full Text]
-
Pepperell, C., Rau, N., Krajden, S., Kern, R., Humar, A., Mederski, B., Simor, A., Low, D. E., McGeer, A., Mazzulli, T., Burton, J., Jaigobin, C., Fearon, M., Artsob, H., Drebot, M. A., Halliday, W., Brunton, J.
(2003). West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ
168: 1399-1405
[Abstract]
[Full Text]
-
Blitvich, B. J., Marlenee, N. L., Hall, R. A., Calisher, C. H., Bowen, R. A., Roehrig, J. T., Komar, N., Langevin, S. A., Beaty, B. J.
(2003). Epitope-Blocking Enzyme-Linked Immunosorbent Assays for the Detection of Serum Antibodies to West Nile Virus in Multiple Avian Species. J. Clin. Microbiol.
41: 1041-1047
[Abstract]
[Full Text]
-
Diamond, M. S., Shrestha, B., Marri, A., Mahan, D., Engle, M.
(2003). B Cells and Antibody Play Critical Roles in the Immediate Defense of Disseminated Infection by West Nile Encephalitis Virus. J. Virol.
77: 2578-2586
[Abstract]
[Full Text]
-
Prince, H. E., Hogrefe, W. R.
(2003). Performance Characteristics of an In-House Assay System Used To Detect West Nile Virus (WNV)-Specific Immunoglobulin M during the 2001 WNV Season in the United States. CVI
10: 177-179
[Abstract]
[Full Text]
-
Martin, D. A., Biggerstaff, B. J., Allen, B., Johnson, A. J., Lanciotti, R. S., Roehrig, J. T.
(2002). Use of Immunoglobulin M Cross-Reactions in Differential Diagnosis of Human Flaviviral Encephalitis Infections in the United States. CVI
9: 544-549
[Abstract]
[Full Text]
-
Craven, R. B., Roehrig, J. T.
(2001). West Nile Virus. JAMA
286: 651-653
[Full Text]
-
Davis, B. S., Chang, G.-J. J., Cropp, B., Roehrig, J. T., Martin, D. A., Mitchell, C. J., Bowen, R., Bunning, M. L.
(2001). West Nile Virus Recombinant DNA Vaccine Protects Mouse and Horse from Virus Challenge and Expresses In Vitro a Noninfectious Recombinant Antigen That Can Be Used in Enzyme-Linked Immunosorbent Assays. J. Virol.
75: 4040-4047
[Abstract]
[Full Text]